Intrexon | Eigenkapital Und Reserven

Aktienkurs
4.93
Täglich Wechseln
0.19 4.01%
Monatlich
11.79%
Jährlich
151.53%
Q1 Prognose
4.78




Eigenkapital Und Reserven Veränderung Datum
Agenus USD -274.14M 80.46M 2025-09
Alaunos Therapeutics USD 2.8M 858K 2025-09
Amgen USD 8.66B 961M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Incyte USD 5.17B 516.28M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Ligand Pharmaceuticals USD 950.17M 121.64M 2025-09
MacroGenics USD 67M 20.38M 2025-09
MannKind USD -44.55M 10.49M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Veracyte USD 1.26B 36.61M 2025-09
Xencor USD 625.32M 4.96M 2025-09


Intrexon Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.